Crossref
Commentary: is segmentectomy curative in patients with early-stage ground glass opacity predominant non-small cell lung cancer?
AME Clinical Trials Review · 2024
DOI: 10.21037/actr-23-38 ↗Kurz gefasst
Fachartikel in der Zeitschrift AME Clinical Trials Review, 2024. Verfasst von Abdulrahman Y. Hammad und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hammad, A. Y., & Fernando, H. C. (2024). Commentary: is segmentectomy curative in patients with early-stage ground glass opacity predominant non-small cell lung cancer?. AME Clinical Trials Review. https://doi.org/10.21037/actr-23-38
Vancouver
Hammad AY, Fernando HC. Commentary: is segmentectomy curative in patients with early-stage ground glass opacity predominant non-small cell lung cancer?. AME Clinical Trials Review. 2024. doi:10.21037/actr-23-38
BibTeX
@article{Hammad2024,
author = {Hammad, Abdulrahman Y. and Fernando, Hiran C.},
title = {Commentary: is segmentectomy curative in patients with early-stage ground glass opacity predominant non-small cell lung cancer?},
journal = {AME Clinical Trials Review},
year = {2024},
doi = {10.21037/actr-23-38}
}
EUVIMED